- Home
- SMTI vs IMMP Comparison
SMTI vs IMMP Comparison
Compare SMTI & IMMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTI
- IMMP
- Stock Information
- Founded
- SMTI 1982
- IMMP 1987
- Country
- SMTI United States
- IMMP Australia
- Employees
- SMTI N/A
- IMMP N/A
- Industry
- SMTI Medical/Dental Instruments
- IMMP Biotechnology: Pharmaceutical Preparations
- Sector
- SMTI Health Care
- IMMP Health Care
- Exchange
- SMTI Nasdaq
- IMMP Nasdaq
- Market Cap
- SMTI 273.6M
- IMMP 251.8M
- IPO Year
- SMTI N/A
- IMMP N/A
- Fundamental
- Price
- SMTI $28.07
- IMMP $1.57
- Analyst Decision
- SMTI Strong Buy
- IMMP Buy
- Analyst Count
- SMTI 2
- IMMP 1
- Target Price
- SMTI $49.50
- IMMP $7.00
- AVG Volume (30 Days)
- SMTI 37.7K
- IMMP 107.8K
- Earning Date
- SMTI 08-11-2025
- IMMP 02-27-2025
- Dividend Yield
- SMTI N/A
- IMMP N/A
- EPS Growth
- SMTI N/A
- IMMP N/A
- EPS
- SMTI N/A
- IMMP N/A
- Revenue
- SMTI $91,569,883.00
- IMMP $3,019,249.00
- Revenue This Year
- SMTI $23.53
- IMMP $50.37
- Revenue Next Year
- SMTI $5.93
- IMMP N/A
- P/E Ratio
- SMTI N/A
- IMMP N/A
- Revenue Growth
- SMTI 34.65
- IMMP 24.11
- 52 Week Low
- SMTI $25.86
- IMMP $1.32
- 52 Week High
- SMTI $39.08
- IMMP $2.80
- Technical
- Relative Strength Index (RSI)
- SMTI 41.55
- IMMP 36.81
- Support Level
- SMTI $26.84
- IMMP $1.51
- Resistance Level
- SMTI $30.36
- IMMP $1.63
- Average True Range (ATR)
- SMTI 1.13
- IMMP 0.08
- MACD
- SMTI -0.01
- IMMP -0.03
- Stochastic Oscillator
- SMTI 34.94
- IMMP 14.63
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.